LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $882,426 | -12.7% | 18,300 | -9.7% | 0.65% | -17.2% |
| Q4 2022 | $1,011,279 | +22.0% | 20,258 | -0.3% | 0.79% | +48.3% |
| Q3 2022 | $829,000 | +35.0% | 20,318 | +82.0% | 0.53% | +62.7% |
| Q2 2022 | $614,000 | +124.9% | 11,163 | +48.5% | 0.33% | +181.9% |
| Q1 2022 | $273,000 | -38.4% | 7,516 | -20.8% | 0.12% | +1.8% |
| Q4 2021 | $443,000 | – | 9,495 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |